Hip disability and Osteoarthritis Outcome Score

Abstract

The Hip disability and Osteoarthritis Outcome Score (HOOS) is a standardized, patient-reported outcome measure (PRO) developed to assess patient-relevant outcomes, symptoms, functional limitations, and health-related quality of life in individuals afflicted with hip osteoarthritis or other hip-related pathologies. Developed by Maria Klässbo and colleagues in 2003 as an adaptation of the Knee Injury and Osteoarthritis Outcome Score (KOOS) and the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC), the HOOS captures both short-term and long-term consequences of hip joint impairments across diverse age groups, ranging from young and active populations to elderly joint arthroplasty recipients. The instrument comprises 40 items operationalized across five discrete subscales: Symptoms (5 items), Pain (10 items), Function in Daily Living [ADL] (17 items), Function in Sport and Recreation (4 items), and Hip-related Quality of Life [QOL] (4 items).

Each item is evaluated on a standardized 5-point Likert scale spanning from 0 (indicating no impairment/never) to 4 (indicating extreme impairment/always). Raw subscale scores are transformed linearly into a standardized metric ranging from 0 to 100, where 0 represents extreme hip problems, incapacitation, or severe symptoms, and 100 denotes total absence of symptoms or unimpaired physiological function. Psychometric evaluations demonstrate excellent internal consistency across subscales, with Cronbach’s alpha coefficients consistently exceeding 0.82 to 0.95. Test-retest reliability is robust, yielding intraclass correlation coefficients (ICC) between 0.78 and 0.96 across diverse patient cohorts. Construct validity has been confirmed via convergent and divergent validity assessments against established indices such as the SF-36 Health Survey, the Oxford Hip Score (OHS), and the visual analogue scale (VAS) for pain. Factor analytic and Rasch validation studies substantiate the multidimensionality of the construct while verifying the clinical responsiveness of each discrete domain following surgical and conservative interventions.

Keywords

Hip disability and Osteoarthritis Outcome Score, HOOS, patient-reported outcome measure, hip osteoarthritis, psychometrics, joint arthroplasty, physical function, pain measurement, quality of life, disability evaluation.

Authors

The original development and psychometric validation of the Hip disability and Osteoarthritis Outcome Score was conducted by a research team led by Maria Klässbo, PT, PhD, in collaboration with Ewa Roos, PT, PhD, and T. Eric Larsson, MD, PhD.

• Maria Klässbo, PT, PhD: Center for Clinical Research, County Council of Värmland, Karlstad, Sweden; and Department of Neuroscience, Physiotherapy, Uppsala University, Uppsala, Sweden. Dr. Klässbo has contributed extensively to musculoskeletal health services research, rehabilitation science, and orthopedic psychometrics.
• Ewa M. Roos, PT, PhD: Professor and Head of Research Unit for Musculoskeletal Function and Physiotherapy, Department of Sports Science and Clinical Biomechanics, University of Southern Denmark, Odense, Denmark. Renowned international authority on osteoarthritis management, joint kinematics, and author of both the KOOS and HOOS outcome instruments.
• T. Eric Larsson, MD, PhD: Department of Orthopedics, Central Hospital, Karlstad, Sweden. Clinical orthopedic surgeon specializing in degenerative hip disorders, arthroplasty epidemiology, and longitudinal surgical outcomes.

The standardized Dutch version was translated, cross-culturally adapted, and psychometrically validated by I. B. de Groot, MSc, J. M. J. Reijman, MD, PhD, M. Terwee, PhD, and colleagues (2007) at the Department of Orthopaedics, Erasmus Medical Center, Rotterdam, The Netherlands.

Purpose

The primary purpose of the Hip disability and Osteoarthritis Outcome Score (HOOS) is to provide a comprehensive, multidimensional, self-administered assessment instrument capable of evaluating both short-term recovery trajectories and long-term functional and psychological consequences of hip disorders. While older instruments such as the Harris Hip Score (HHS) heavily integrated clinician-administered physical examinations, passive range-of-motion assessments, and physician impressions, modern healthcare paradigms recognize that clinician-rated metrics often correlate poorly with patient-perceived functional impairment, personal disability, and subjective pain tolerance. The HOOS was developed to ensure that the patient’s perspective remains central in tracking treatment success, clinical progression, and postoperative rehabilitation.

In clinical practice, the instrument is utilized across both non-operative and operative settings. Non-operative indications include physical therapy, therapeutic exercise regimens, lifestyle modifications, weight loss programs, pharmacological interventions (e.g., non-steroidal anti-inflammatory drugs), and intra-articular injections (corticosteroid or hyaluronic acid). Operative applications encompass hip arthroscopy for femoroacetabular impingement (FAI), periacetabular osteotomy, hip resurfacing, and total hip arthroplasty (THA). Because the HOOS was specifically designed to bridge the gap between young, high-functioning active individuals and older, sedentary patients undergoing end-stage joint replacement, it includes items addressing high-demand physical functions (such as running, twisting, and deep squatting) alongside fundamental activities of daily living (such as rising from bed, ascending stairs, and donning socks).

In biomedical and clinical trial research, the HOOS functions as a standardized primary or secondary endpoint. By assessing distinct domains independently rather than combining them into a single aggregate aggregate score, researchers can avoid obscuring clinically critical discrepancies. For instance, an intervention might significantly alleviate resting nocturnal pain without substantially restoring high-impact athletic performance; a single combined score would conflate these disparate physiological domains. By maintaining five discrete transformed domain scores, the HOOS provides researchers and clinicians with a granular, unmasked profile of patient status across symptoms, pain, basic mobility, demanding recreational capacity, and psychosocial well-being.

Psychological Construct

The HOOS captures the multifaceted construct of musculoskeletal health-related disability, which is inherently biopsychosocial. Pain and joint degeneration do not exist within a biological vacuum; they deeply alter an individual’s behavioral patterns, affective status, self-efficacy, and perceived identity. The instrument divides this overarching construct into five operationalized domains:

1. Symptoms (5 items)

This subscale assesses the sensory, mechanical, and neuro-functional manifestations of hip pathology apart from acute pain. It includes items measuring mechanical joint sensations (grinding, clicking, snapping, or abnormal intra-articular noises), mechanical range-of-motion restrictions (difficulty spreading legs or taking full strides while walking), and the duration and severity of joint stiffness. Stiffness is evaluated both after initial awakening in the morning (reflecting the classic inflammatory “gelling phenomenon” characteristic of osteoarthritis) and after prolonged sitting, lying, or resting during the day. Psychologically, severe morning and daytime stiffness serves as a chronic cue that disrupts morning routines, increases somatic vigilance, and elevates fear of movement (kinesiophobia).

2. Pain (10 items)

Pain in the HOOS is conceptualized as a multidimensional noxious experience that varies across both temporal frequency and mechanical load. The subscale evaluates constant versus intermittent pain, ranging from overall frequency (how often the joint hurts) to mechanical provocation during specific physiological tasks: straightening the hip fully, bending the hip fully, ambulating on flat, hard, or uneven surfaces, negotiating stairs, and enduring resting positions. Crucially, nocturnal pain (pain at night while in bed) and static resting pain (sitting or lying) are evaluated, which represent profound markers of severe joint inflammation and nocturnal sleep disturbance—factors linked to depressive symptoms and psychological distress in chronic pain populations.

3. Function in Daily Living [ADL] (17 items)

The ADL subscale examines perceived physical limitations in basic, self-care, and community mobility activities necessary for functional autonomy. Based directly on the foundational construct of the WOMAC index, these items span basic lower-extremity tasks: stair descent, stair ascent, rising from sitting, standing stationary, bending down to retrieve objects from the floor, walking on flat terrain, entering/exiting motor vehicles, carrying out shopping, putting on and taking off socks or stockings, rising from bed, turning over in bed, bathing, sitting, using the toilet, and performing light versus heavy domestic chores. The psychological significance of ADL deficits lies in the erosion of personal independence, generating feelings of helplessness, heightened caregiver burden, and decreased perceived self-competence.

4. Function in Sport and Recreation (4 items)

Many traditional orthopedic measures suffered from severe “ceiling effects,” failing to differentiate clinical outcomes among active, younger, or mid-life patients who demand higher physiological capacity than basic walking. The HOOS Sport/Recreation subscale addresses demanding physical activities: deep squatting, running, twisting or pivoting on a loaded leg, and walking on challenging uneven ground. Inability to execute these tasks disrupts identity-affirming recreational roles, sports participation, and peer socialization, often contributing to athletic identity loss, social isolation, and behavioral avoidance.

5. Hip-Related Quality of Life [QOL] (4 items)

This explicitly psychosocial dimension assesses the cognitive and emotional impact of living with chronic hip impairment. The items measure: joint awareness (frequency of conscious cognitive intrusion caused by the hip), behavioral modification (restricting or modifying lifestyle to avoid joint damage), lack of confidence in the joint (hip-specific fear-avoidance and perceived joint instability), and global perceived hip difficulty. This domain directly interfaces with cognitive appraisals, perceived vulnerability, and catastrophizing, capturing how the biological disorder transforms personal lifestyle and psychological peace of mind.

Theoretical Framework

The HOOS is grounded theoretically within the World Health Organization’s International Classification of Functioning, Disability and Health (ICF) framework, alongside contemporary biopsychosocial models of chronic pain and disability.

Under the ICF framework, human functioning is conceptualized as a dynamic interaction between health conditions (structural and physiological pathology) and contextual factors (environmental and personal factors). The ICF organizes disablement into three distinct yet interrelated levels:

1. Body Functions and Structures: Impairments in structural integrity, articular cartilage degeneration, subchondral sclerosis, capsular tightness, and nociceptive neurological signaling. In the HOOS, this is primarily tapped through the Symptoms and Pain subscales.
2. Activities: The execution of individual tasks or actions. The HOOS captures this through the ADL subscale (basic tasks such as rising from a chair, ascending stairs, and personal hygiene) and the Sport/Recreation subscale (complex functional motor patterns requiring agility, strength, and endurance).
3. Participation: Involvement in real-world life situations, encompassing occupational performance, leisure pursuits, social engagement, and family roles. In the HOOS, this is evaluated through the Hip-related Quality of Life subscale, particularly questions probing lifestyle modification and social role constraints.

Concurrently, the HOOS operationalizes principles derived from the Fear-Avoidance Model of musculoskeletal pain (Vlaeyen & Linton, 2000). According to this cognitive-behavioral framework, when individuals interpret musculoskeletal nociceptive sensations as indicative of progressive joint destruction, they develop pain catastrophizing and fear of movement. This manifests empirically in hypervigilant monitoring of joint status (“How often are you aware of your hip problem?”), self-imposed restrictions on daily activities (“Have you modified your life style to avoid activities potentially damaging to your hip?”), and behavioral avoidance triggered by joint instability or fear (“How much are you troubled with lack of confidence in your hip?”). By capturing both physiological task execution and psychological avoidance beliefs, the HOOS reflects the complete continuum of chronic musculoskeletal disablement.

Validity

The psychometric validity of the HOOS has been rigorously demonstrated across diverse cultural populations, clinical environments, and surgical contexts.

Construct and Convergent Validity

In the seminal validation study by Klässbo et al. (2003), construct validity was established by comparing HOOS subscales with established reference measures, including the SF-36 Health Survey, the Lequesne Index, and visual analogue scales (VAS) for pain. Strong convergent validity was observed between conceptually aligned subscales. Specifically, the HOOS Pain subscale correlated strongly with the SF-36 Bodily Pain domain ($r = 0.75$ to $0.83$) and VAS Pain ($r = -0.72$ to $-0.80$). The HOOS ADL subscale demonstrated high correlations with the SF-36 Physical Functioning domain ($r = 0.74$ to $0.85$). In contrast, discriminant validity was confirmed by significantly lower, weak-to-moderate correlations between HOOS physical subscales and the SF-36 Mental Health and Role Emotional domains ($r = 0.18$ to $0.34$), confirming that the HOOS discriminates physical hip disability from general psychological well-being.

Cross-cultural adaptation studies across Dutch (de Groot et al., 2007), French (Ornetti et al., 2009), German (Nilsdotter et al., 2003), and Spanish cohorts have replicated these convergent patterns. The Dutch validation confirmed high correlations between the HOOS subscales and corresponding WOMAC subscales (correlations ranging from $r = 0.86$ to $0.94$), confirming that the HOOS retains the full measurement integrity of the WOMAC while providing additional discriminative sensitivity in younger, more active cohorts through its Sport/Rec and QOL domains.

Content and Criterion Validity

Content validity was ensured during initial development via qualitative focus groups involving orthopedic surgeons, physical therapists, and patients presenting with varying stages of hip osteoarthritis. Patients actively contributed to item generation, confirming that questions accurately represented daily challenges, mechanical symptoms, and psychosocial dilemmas. Unlike earlier clinician-reported metrics, the self-administered nature of the HOOS eliminates observer-expectancy bias, yielding robust criterion validity against functional performance tests such as the 6-Minute Walk Test, Timed Up and Go (TUG), and stair-climb performance tasks.

Responsiveness and Longitudinal Sensitivity

The HOOS has demonstrated exceptional responsiveness to clinical change following total hip arthroplasty, joint-preserving surgery, and intensive rehabilitation. Standardized Response Means (SRM) and Effect Sizes (ES) following total hip arthroplasty routinely exceed $1.2$ to $2.5$ across the Pain, ADL, and QOL subscales at 6 and 12 months postoperative. The Sport/Recreation subscale demonstrates high responsiveness in younger populations undergoing periacetabular osteotomy or arthroscopic labral repair, where traditional outcome measures exhibit severe ceiling effects prior to surgery.

Reliability

The reliability of the HOOS has been exhaustively analyzed across multiple investigations, focusing on internal consistency, test-retest reproducibility, and measurement error margins.

Internal Consistency

Internal consistency evaluates the degree to which items within a given subscale measure the same underlying construct. Across validation cohorts, Cronbach’s alpha coefficients consistently meet or exceed the standard psychometric threshold of $0.80$ for group comparisons and $0.90$ for individual clinical decision-making:

• Symptoms: $\alpha = 0.78 – 0.86$
• Pain: $\alpha = 0.90 – 0.95$
• Function in Daily Living (ADL): $\alpha = 0.94 – 0.98$
• Function in Sport and Recreation: $\alpha = 0.86 – 0.93$
• Hip-Related Quality of Life: $\alpha = 0.82 – 0.90$

Test-Retest Reliability and Intraclass Correlation Coefficients

Test-retest reliability has been established in clinically stable patient cohorts over test intervals ranging from 7 to 21 days. Intraclass correlation coefficients (ICC, two-way mixed effects model, absolute agreement) demonstrate high stability:

• Symptoms: $\text{ICC} = 0.78 – 0.89$
• Pain: $\text{ICC} = 0.85 – 0.93$
• ADL: $\text{ICC} = 0.88 – 0.96$
• Sport/Recreation: $\text{ICC} = 0.79 – 0.91$
• Quality of Life: $\text{ICC} = 0.83 – 0.94$

Measurement Error: SEM and MDC

The Standard Error of Measurement (SEM) and Minimal Detectable Change (MDC) at the 95% confidence level ($ ext{MDC}_{95}$) have been rigorously defined. Depending on the subscale and patient cohort, the SEM ranges between$5.0$ and $8.5$ points on the 0–100 transformed metric. Consequently, the individual $ ext{MDC}_{95}$ values generally range between $9$ and $14$ points. In longitudinal clinical trials, the Minimal Clinically Important Difference (MCID) is commonly estimated at $8$ to $12$ points, ensuring that clinicians can differentiate true physiological improvement from baseline measurement noise.

Factor Analysis

Both Exploratory Factor Analysis (EFA) and Confirmatory Factor Analysis (CFA) have been utilized to evaluate the structural integrity and dimensionality of the HOOS.

Exploratory Factor Analyses

Early principal component and common factor analyses with oblique (Promax or Oblimin) rotation confirmed that the 40 items load predominantly across the five hypothesized dimensions. Items within the ADL and Pain domains share substantial variance, as physical movement invariably interacts with nociceptive sensation in degenerative joint pathology. However, factor solutions consistently isolate the Sport and Recreation items and the Hip-related Quality of Life items as independent factors, confirming that these subscales capture variance that is not addressed by basic daily functional measures.

Confirmatory Factor Analyses and Structural Fit

Confirmatory factor models testing the proposed five-factor structure have demonstrated acceptable to strong goodness-of-fit indices in clinical cohorts:

• Comparative Fit Index (CFI): Values typically range between $0.91$ and $0.96$, surpassing the acceptable threshold of $0.90$.
• Tucker-Lewis Index (TLI): Coefficients regularly span $0.90$ to $0.95$.
• Root Mean Square Error of Approximation (RMSEA): Estimates fall between $0.052$ and $0.076$, indicating adequate to close model fit.
• Standardized Root Mean Square Residual (SRMR): Typically $< 0.06$.

Item factor loadings ($lambda$) are robust across all five subscales. For the Pain subscale, standardized loadings range from $0.68$ to $0.89$. The ADL subscale exhibits high item loadings between $0.72$ and $0.92$. The Sport/Rec items load strongly between $0.75$ and $0.91$, and the QOL items yield factor loadings between $0.71$ and $0.88$.

Item Response Theory and Rasch Modeling

Modern psychometric investigations employing Rasch analysis and Item Response Theory (IRT) have examined item fit statistics (Infit and Outfit Mean Squares). While the 17-item ADL subscale exhibits some redundancy (item collinearity) due to narrow item difficulty thresholds, it offers exceptionally high measurement precision across moderate-to-severe impairment levels. Rasch analyses also demonstrate that the 5-point Likert response scale functions monotonically without disordered thresholds, confirming that patients reliably differentiate between response categories (None, Mild, Moderate, Severe, and Extreme).

Instrument / Measurement Tool

• Test Type: Patient-Reported Outcome Measure (PROM); self-administered questionnaire.
• Format: Pen-and-paper, electronic clinical tablet, web-based survey portal.
• Number of Items: 40 items.
• Subscales (5):
  • Symptoms (S): 5 items (grinding/clicking, spreading legs, full strides, morning stiffness, daytime stiffness).
  • Pain (P): 10 items (frequency, fully straightening, fully bending, walking on flat, stairs, nocturnal, sitting/lying, standing, hard surface, uneven surface).
  • Function in Daily Living [ADL] (A): 17 items (descending stairs, ascending stairs, rising from sitting, standing, bending, walking flat, car entry/exit, shopping, donning socks, rising from bed, doffing socks, lying in bed, bath entry/exit, sitting, toilet transfers, heavy domestic, light domestic).
  • Function in Sport and Recreation [SP]: 4 items (squatting, running, twisting/pivoting, walking on uneven surfaces).
  • Hip-Related Quality of Life [QOL]: 4 items (joint awareness, lifestyle modification, lack of confidence, overall difficulty).
• Response Scale: Standardized 5-point Likert scale (0 to 4):
  • 0 = None / Never
  • 1 = Mild / Rarely
  • 2 = Moderate / Sometimes
  • 3 = Severe / Often
  • 4 = Extreme / Always
• Recall Period: The preceding week (“the last week”).
• Completion Time: Approximately 8 to 12 minutes.
• Scoring and Transformation Rules:
  • Each item is assigned a raw score from 0 to 4.
  • The five subscales are scored and analyzed independently. No aggregate global total score should be calculated, as combining distinct dimensions masks domain-specific clinical changes.
  • Raw scores for each subscale are calculated either as a sum or mean of completed items.
  • Normalized transformed score formula:
    
    Normalized Score = 100 - [(mean score of subscale items / 4) * 100]
  • Equivalently, using the sum of items:
    
    Normalized Score = 100 - [(sum of item scores in subscale) / (number of items * 4) * 100]
  • Interpretation: Scores range from 0 to 100, where 0 indicates extreme hip problems, severe pain, and total functional limitation, and 100 indicates an absence of symptoms, pain-free joint status, and unimpaired function.
  • Missing Data Imputation: If at least 50% of the items within a subscale are answered, a mean score can be calculated from the available items. If more than 50% of the items in a subscale are missing, the subscale score is classified as invalid and left uncalculated.

Permissions & Fee and Test Year

The Hip disability and Osteoarthritis Outcome Score (HOOS) was first published in 2003 by Maria Klässbo and colleagues. The instrument is considered open-access and free of charge for non-commercial clinical use, academic research, and non-funded clinical trials. It was intentionally placed in the public domain by its creators to encourage universal standardization of hip outcome monitoring.

Official user guidelines, validated multilingual translations, and scoring manuals are hosted and maintained through international collaborative initiatives including the Swedish KOOS/HOOS clinical research network (www.koos.nu). Commercial organizations, pharmaceutical corporations, and for-profit clinical trial sponsors are generally requested to seek registration or contact the authors to secure license verification and support outcome data harmonization. Modification of item wording, altering response scales, or computing unauthorized total composite scores is strictly discouraged, as it undermines psychometric comparability across international joint registries.

References

• de Groot, I. B., Reijman, M., Terwee, C. B., Bierma-Zeinstra, S. M. A., Favejee, C., Roos, E. M., & Verhaar, J. A. N. (2007). Validation study of the Dutch Hip disability and Osteoarthritis Outcome Score (HOOS). Osteoarthritis and Cartilage, 15(1), 104–109. https://doi.org/10.1016/j.joca.2006.06.014
• Klässbo, M., Larsson, E., & Roos, E. M. (2003). The Hip disability and Osteoarthritis Outcome Score (HOOS)—validity and responsiveness in total hip replacement. Osteoarthritis and Cartilage, 11(11), 805–815. https://doi.org/10.1016/S1063-4584(03)00164-9
• Nilsdotter, A. K., Lohmander, L. S., Klässbo, M., & Roos, E. M. (2003). Hip disability and osteoarthritis outcome score (HOOS)—validity and responsiveness in total hip replacement. BMC Musculoskeletal Disorders, 4, Article 10. https://doi.org/10.1186/1471-2474-4-10
• Ornetti, P., Parratte, S., Gossec, L., Tavernier, C., Argenson, J. N., Roos, E. M., & Maillefert, J. F. (2009). Cross-cultural adaptation and validation of the French version of the Hip disability and Osteoarthritis Outcome Score (HOOS) in hip osteoarthritis patients. Osteoarthritis and Cartilage, 17(1), 60–64. https://doi.org/10.1016/j.joca.2008.05.007
• Roos, E. M., & Lohmander, L. S. (2003). The Knee injury and Osteoarthritis Outcome Score (KOOS): from joint injury to osteoarthritis. Health and Quality of Life Outcomes, 1, Article 64. https://doi.org/10.1186/1477-7525-1-64
• Vlaeyen, J. W. S., & Linton, S. J. (2000). Fear-avoidance and its consequences in chronic musculoskeletal pain: A state of the art. Pain, 85(3), 317–332. https://doi.org/10.1016/S0304-3959(99)00242-0

Items of the Scale